
|Articles|January 1, 2003
Botox battles heat up
Author(s)Timothy N. Troy
Palm Beach, Fla. - Dermatologists apparently have had enough hype, spam, and promotion of new retail creams claiming to be "better" than mainstay anti-aging products. The upshot is a first-ever clinical comparison of such topicals to botulinum toxin A, a wrinkle fighter turned household word by Allergan's Botox Cosmetic.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
2
Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial
3
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











